FDA Adverse Event Injury Summary report: N

XIENCE XPEDITION

MDR report key: 9759037 · Received February 26, 2020

Report

Report Number
2024168-2020-01809
Event Type
Injury
Date Received
February 26, 2020
Date of Event
January 27, 2020
Report Date
February 26, 2020
Manufacturer
ABBOTT VASCULAR
Product Code
NIQ
PMA / PMN Number
P110019
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED FOR EVALUATION. A REVIEW OF THE LOT HISTORY RECORD IDENTIFIED NO MANUFACTURING NONCONFORMITIES ISSUED TO THE REPORTED LOT THAT WOULD HAVE CONTRIBUTED TO THIS EVENT. IT SHOULD BE NOTED THAT THE REPORTED PATIENT EFFECT OF DISSECTION IS LISTED IN THE XIENCE PRO 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEMS INSTRUCTIONS FOR USE AS A KNOWN PATIENT EFFECT OF CORONARY STENTING PROCEDURES. A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT(S), AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED. HOWEVER, THE TREATMENT APPEARS TO BE RELATED TO THE OPERATIONAL CONTEXT OF THE PROCEDURE. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.

Description of Event or Problem · 1

PATIENT ID: (B)(6). IT WAS REPORTED THAT ON (B)(6) 2020, THE PATIENT PRESENTED WITH A RECENT ST ELEVATED MYOCARDIAL INFARCTION (STEMI) AND A PERCUTANEOUS CORONARY INTERVENTION (PCI) WAS PERFORMED. PRE-DILATATION WAS PERFORMED ON THE PROXIMAL RIGHT CORONARY ARTERY (RCA), 80% STENOSED LESION AND A 3.0X48MM (1017300-48, 9080641) XIENCE PRO STENT WAS IMPLANTED. FOLLOWING, A DISSECTION OCCURRED, TREATED AND OVERLAPPED WITH ANOTHER STENT, A 3.5X8MM (1500350-08, 8010541) XIENCE PRO STENT. THE DISSECTION RESOLVED. REPORTEDLY, THE ANGIOGRAPHIC RESULTS WERE ACCEPTABLE, 0% STENOSIS AND TIMI FLOW III. THERE WAS NO DEVICE MALFUNCTION. NO ADDITIONAL INFORMATION WAS PROVIDED REGARDING THIS ISSUE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
217003 XIENCE XPEDITION DRUG ELUTING CORONARY STENT DELIVERY SYSTEM NIQ ABBOTT VASCULAR 9080641

Patients

Seq Age Sex Outcome Treatment
1 64 YR Required Intervention